Eiko LifeSciences Limited

BSE:540204 Stock Report

Market Cap: ₹715.6m

Eiko LifeSciences Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Umesh More

Chief executive officer

₹600.0k

Total compensation

CEO salary percentagen/a
CEO tenure3.4yrs
CEO ownershipn/a
Management average tenure2.9yrs
Board average tenure4.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Umesh More's remuneration changed compared to Eiko LifeSciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

₹12m

Jun 30 2024n/an/a

₹10m

Mar 31 2024₹600kn/a

₹8m

Dec 31 2023n/an/a

₹7m

Sep 30 2023n/an/a

₹7m

Jun 30 2023n/an/a

₹8m

Mar 31 2023₹600k₹600k

₹8m

Dec 31 2022n/an/a

₹6m

Jun 30 2022n/an/a

₹4m

Mar 31 2022₹450k₹450k

₹7m

Compensation vs Market: Umesh's total compensation ($USD6.93K) is below average for companies of similar size in the Indian market ($USD41.73K).

Compensation vs Earnings: Umesh's compensation has been consistent with company performance over the past year.

CEO

Umesh More

3.4yrs

Tenure

₹600,000

Compensation

Mr. Umesh Ravindranath More serves as Additional Executive Director at Eiko LifeSciences Limited (formerly known as Narendra Investments (Delhi) Limited) since November 12, 2020 and also serves as its Whol...

Leadership Team

NamePositionTenureCompensationOwnership
Umesh More
Whole-Time Director3.4yrs₹600.00kno data
Jaid Kojar
Chief Financial Officer2.9yrs₹780.00k0.39%
₹ 2.8m
Chintan Doshi
Company Secretary & Compliance Officer1.2yrs₹94.00kno data

2.9yrs

Average Tenure

Experienced Management: 540204's management team is considered experienced (2.9 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Umesh More
Whole-Time Director4.2yrs₹600.00kno data
Laxmikant Kabra
Non-Executive Chairman11.4yrsno data11.94%
₹ 85.4m
Bhavesh Tanna
Non-Executive Non-Independent Director11.4yrsno data3.03%
₹ 21.7m
Kajal Kothari
Non-Executive Independent Director4.3yrsno datano data
Rajkumar Baheti
Non-Executive - Independent Director3.9yrsno datano data
Hasti Doshi
Independent Directorless than a yearno datano data

4.3yrs

Average Tenure

48yo

Average Age

Experienced Board: 540204's board of directors are considered experienced (4.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/28 22:32
End of Day Share Price 2025/01/28 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Eiko LifeSciences Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution